Ghasemi Habib, Schmidt Henrik, Stolle Lars Bjørn
Ortopædkirurgisk Afdeling E, Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C.
Ugeskr Laeger. 2015 Jan 26;177(2A):108-9.
Until recently metastatic melanoma was a disease with limited treatment options and a poor prognosis. However, new promising products have been developed. Ipilimumab, a full human anti-cytotoxic T-lymphocyte antigen-4 antibody, has shown improved survival in several clinical trials and is now a part of the standard treatment options for this disease in Denmark. In this case report we present a 78-year-old man with metastatic melanoma who had complete remission after treatment with ipilimumab.
直到最近，转移性黑色素瘤还是一种治疗选择有限且预后较差的疾病。然而，已经研发出了一些有前景的新产品。伊匹单抗是一种全人源抗细胞毒性T淋巴细胞抗原4抗体，在多项临床试验中已显示出能提高生存率，目前在丹麦已成为这种疾病标准治疗方案的一部分。在本病例报告中，我们介绍了一名78岁的转移性黑色素瘤男性患者，其在用伊匹单抗治疗后实现了完全缓解。
